Boniva

Boniva® (Ibandronate Sodium)

Boniva® (Ibandronate Sodium) is used to treat and prevent osteoporosis in postmenopausal women. It is administered intravenously approximately every three months. Doing so may help reduce bone loss for up to five years. Whether to continue with infusion therapy after five years depends on the patient’s medical history and specific needs.

Speak with your healthcare provider to learn if this drug is right for you.

Boniva® (Ibandronate Sodium) Referral Form

MANUFACTURER:

Roche Therapeutics Inc.

CLASS:
Bisphosphonate
WHAT IT TREATS:
PRESCRIBED BY:

Rheumatologists
Endocrinologists

HOW ADMINISTERED:
IV Infusion
FREQUENCY:

Administered once every three months.

Length of infusion:
15 - 30 seconds
FOR MORE INFORMATION: